Table 3. MF exposure and the risk of abnormal embryonic development.
| Maternal MF exposure | |||
| Embryonic development | ≥0.82 mG | <0.82 mG | aOR (95% CI)a |
| N (%) | N (%) | ||
| Embryonic sac length | |||
| ≤25th percentile (20 mm) | 22 (31.88) | 14 (22.95) | 1.56 (0.70,3.48) |
| >25th percentile | 47 (68.12) | 47 (77.05) | |
| Embryonic bud length | |||
| ≤25th percentile (7 mm) | 14 (45.16) | 5 (14.71) | 3.95 (1.10,14.20) |
| >25th percentile | 17 (55.84) | 29 (85.29) | |
| Apoptosis grayscale | |||
| ≥75th percentile (150.828) | 9 (13.04) | 11 (18.03) | 0.87 (0.31,2.41) |
| <75th percentile | 60 (86.96) | 50 (81.97) | |
a
Adjusted for subjects' age, education and gestational age.